You optimize CMC and quality compliance workflows by using platforms that centralize data, automate documentation, enforce audit-ready processes, and accelerate regulatory submissions. These tools eliminate inefficiencies and strengthen compliance oversight.
This guide covers seven leading platforms designed for biotech and pharma operations. You’ll learn what each does best, how they fit into regulatory strategies, and where they add measurable value to compliance.
1. QbDVision – Digital CMC Lifecycle Management
QbDVision is built to manage the complexity of Chemistry, Manufacturing, and Controls in a structured, digital environment. It captures product knowledge, process development, analytical methods, and manufacturing variability in one system.
You can replace scattered spreadsheets and unlinked documents with standardized workflows. QbDVision enables you to assess risk, design experiments, and monitor critical process parameters with full traceability. This makes regulatory submissions more reliable, since all supporting data is embedded and searchable.
When scaling biologics or cell therapies, you need fast tech transfer with minimal error. QbDVision gives you that control while keeping compliance intact.
2. Mareana CMC – Process Agility and Real-Time Monitoring
Mareana CMC specializes in manufacturing intelligence. It helps you monitor multiple data streams, including batch results, analytical data, and stability studies.
By implementing Mareana, you align upstream laboratory activities with downstream process control. This ensures that quality metrics are integrated into decision-making before a deviation escalates into a regulatory concern.
Smaller biotech firms find Mareana useful for transitioning from pilot production to commercial scale, where oversight can often slip if systems aren’t unified. With its SaaS model, you can scale operations without major infrastructure build-out.
3. ComplianceQuest – Cloud QMS with Regulatory Depth
ComplianceQuest provides a validated Quality Management System (QMS) with audit-ready workflows. You get document control, CAPA, supplier qualification, and change management in one interface.
This platform is particularly effective when regulatory teams and quality groups must collaborate closely. For instance, CMC submissions often rely on QC batch release and supplier audits. ComplianceQuest keeps both functions aligned with transparent workflows and records.
Using a cloud-native QMS also allows you to maintain real-time audit trails, which reduces inspection findings and shortens response times to regulator queries.
4. Docuvera – Structured Documentation for Regulatory Submissions
Docuvera takes a modular approach to documentation. It lets you create structured content blocks that can be reused across submissions, variations, and updates.
This structured model saves time when you must submit eCTD documents to multiple agencies. Instead of rewriting the same content, you update one module and cascade it across all relevant outputs.
Docuvera’s impact analysis feature also helps you identify where a single change affects multiple dossiers. This reduces the risk of omissions and ensures faster, compliant variation management.
5. Genedata – QC Data Integration and Batch Characterization
Genedata integrates data from R&D, QC, stability testing, and manufacturing. It’s especially strong for analytical workflows such as chromatography, spectroscopy, and mass spectrometry.
You gain consistent data flow from early-stage development to commercial QC. That reduces errors during method transfers and builds a stronger foundation for regulatory documentation.
Firms using Genedata report fewer integrity issues and faster decisions during batch release. By improving trust in lab-generated data, you eliminate one of the most common bottlenecks in compliance.
6. AssurX – Risk and Deviation Oversight
AssurX focuses on compliance risk management. It helps you track deviations, assign corrective actions, and manage change control.
By using AssurX, you can prevent recurring issues from slipping through oversight. The platform provides dashboards that show where quality incidents originate, how they escalate, and what corrective actions are effective.
This level of visibility allows you to anticipate inspection findings and demonstrate control to regulators, which is particularly critical when working with biologics or highly regulated therapies.
7. Dassault Systèmes 3DEXPERIENCE – Collaborative CMC Authoring
Dassault’s 3DEXPERIENCE platform provides collaborative authoring for regulatory documents. Multiple stakeholders can contribute to submissions without version control conflicts.
Its automation features allow you to reuse validated content across documents. This reduces manual editing, improves accuracy, and accelerates the submission timeline.
For large organizations with multiple manufacturing sites or partnerships with CDMOs, Dassault’s authoring platform ensures consistency across all regulated outputs, including Module 3 of the eCTD.
Key Criteria for Choosing a Platform
When selecting a platform, you should focus on:
- Audit trail and compliance with regulations (21 CFR Part 11, EU equivalents)
- Integration with LIMS, MES, and CDMO systems
- Support for structured submissions (eCTD, variation management)
- Flexibility for scaling operations across sites or products
- Risk and CAPA management tools
These criteria ensure you implement a system that supports compliance while boosting efficiency.
What are the best platforms for CMC and quality compliance?
- QbDVision: Digital lifecycle management
- Docuvera: Structured documentation and submissions
- Genedata: QC and batch data integration
In Conclusion
You strengthen CMC and quality compliance workflows by adopting platforms designed to centralize data, enforce structure, and automate oversight. QbDVision, Mareana, ComplianceQuest, Docuvera, Genedata, AssurX, and Dassault’s 3DEXPERIENCE all address critical gaps in biotech workflows. By selecting the right system for your scale and regulatory demands, you move faster, stay compliant, and reduce submission delays.
Nirdosh Jagota is Managing Partner at GRQ Biotech Advisors with 30+ years in the biotech industry. A former executive at Amgen, Genentech/Roche, Merck, and Pfizer, he has led >25 NDAs/BLAs/MAAs and hundreds of INDs across global regulatory, quality, and compliance.
